Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2024-12-28T05:31:44.706Z Has data issue: false hasContentIssue false

Closing the Organ Gap: A Reciprocity-Based Social Contract Approach

Published online by Cambridge University Press:  01 January 2021

Extract

Organ transplantation remains one of modern medicine's remarkable achievements. It saves lives, improves quality of life, diminishes healthcare expenditures in end-stage renal patients, and enjoys high success rates. Yet the promise of transplantation is substantially compromised by the scarcity of organs. The gap between the number of patients on waiting lists and the number of available organs continues to grow. As of January 2006, the combined waiting list for all organs in the United States was 90,284 (64,933, 17,269, and 3,006 for kidney, liver, and heart respectively). Unfortunately, thousands of potential organs are lost each year, primarily due to lack of consent to donation from the deceased before death, or from the family thereafter. Only fifty percent of potential donors – the “conversion” rate – become actual donors. The costs attributed to organ shortage are substantial – Medicare paid over $15.5 billion in 2002 for treating patients with end-stage renal-disease, who predominate on organ waiting lists.

Type
Independent
Copyright
Copyright © American Society of Law, Medicine and Ethics 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Current data on waiting lists in the United States, available through <http://www.optn.org> (last visited January 17, 2006).+(last+visited+January+17,+2006).>Google Scholar
Sheehy, E., Conrad, S. L., Brigham, L. E. et al., “Estimating the Number of Potential Organ Donors in The United States,” New Eng. J. Med. 349 (2003): 667674.CrossRefGoogle Scholar
Eggers, P. W., “Medicare End Stage Renal Disease Program,” Health Care Financing Review 22 (2000): 5560; United States Renal Data System, at <http://www.usrds.org/2004/ref/K_tables_04.pdf> (last visited January 17, 2006).Google Scholar
Waiting list data, supra note 1.Google Scholar
The Organ Donation Breakthrough Collaborative: Best Practices Final Report, September 2003, at <http://www.organdonor.gov/bestpractice.htm> (last visited January 17, 2006).+(last+visited+January+17,+2006).>Google Scholar
Organ Donation and Recovery Improvement Act, P.L. 108–216, section 8.Google Scholar
Strategies for Cadaveric Organ Procurement, “Mandated Choice and Presumed Consent,” Council on Ethical and Judicial Affairs Report, JAMA 272 (1994): 809812, available at <http://www.ama-assn.org/ama/pub/category/8446.html> (last visited January 17, 2006).CrossRef+(last+visited+January+17,+2006).>Google Scholar
Both Texas and Virginia have tried mandated choice with disappointing results. In Texas, 80% of those forced to make a choice said no. See Siminoff, L. A. and Mercer, M. B., “Public Policy, Public Opinion, and Consent for Organ Donation,” Cambridge Quarterly Healthcare Ethics 10 (2001): 377–86. When Virginia adopted a policy of mandated choice, only 31% committed to donation. See Klassen, A. C. and Klassen, D. K., “Who Are the Donors in Organ Donation? The Family's Perspective in Mandated Choice,” Annals of Internal Medicine 125 (1996): 70–73.CrossRefGoogle Scholar
Childress, J. F., “The Failure to Give: Reducing Barriers to Organ Donation,” Kennedy Institute of Ethics Journal 11 (2001): 116; Chouhan, P. and Draper, H., “Modified Mandated Choice for Organ Procurement,” Journal of Medical Ethics 29 (2003):157–162. Based on concerns about the actual effects of mandated choice on donation, The AMA recently updated and revised its opinion on mandated choice, supporting “properly designed pilot studies,” while discouraging widespread implementation in the absence of “data that suggest a positive effect on donation.” Council on Ethical and Judicial Affairs (CEJA), American Medical Association. 1995. Presumed Consent and Mandated Choice for Organs from Deceased Donors, Opinion 4–I-05, rescinding and modifying Opinion E-2.155, supra, note 8.CrossRefGoogle Scholar
Epstein, R., Mortal Peril: Our Inalienable Right to Health Care? (Cambridge, Massachusetts: Perseus Books, 1997): at 249–261; Veatch, R. M., “Why Liberals Should Accept Financial Incentives for Organ Procurement,” Kennedy Institute of Ethics Journal 13 (2003): 19–36; Cohen, L. R., “Increasing the Supply of Transplant Organs: The Virtues of a Futures Market,” George Washington Law Review 58 (1989): 1–51; Steinberg, D., “An ‘Opting In’ Paradigm for Kidney Transplantation,” American Journal of Bioethics 4 (2004): 4–14.Google Scholar
See Childress, supra note 10; Delmonico, F. L., Robert, A., Schper-Hughes, N. et al., “Ethical Incentives – Not Payment – for Organ Donors,” New Eng. J. Med. 346 (2002): 20022005.CrossRefGoogle Scholar
The National Organ Transplant Act, 42 U.S.C. § 273–274 (P.L. 98–507).Google Scholar
Harris, J., The Value of Life (London: Routledge, 1985): at 118–19.Google Scholar
Etzioni, A., “Organ Donation: A Communitarian Approach,” Kennedy Institute of Ethics Journal 13 (2003): 118.CrossRefGoogle Scholar
Eaton, S., “The Subtle Politics of Organ Donation: A Proposal,” Journal of Medical Ethics 24 (1998): 166170; Muyskens, J., “Should Receiving Depend Upon Willingness to Give?” Transplantation Proceedings 24 (1992): 2181–2184; Schwindt, R., Vining, A., “Proposal for a Mutual Insurance Pool for Transplant Organs,” Journal of Health Politics, Policy & Law 23 (1998): 725–741; Undis, D. J., “Life Sharers: Increasing Organ Supply Through Directed Donation,” American Journal of Bioethics 5, no. 4 (2005): 22–24.CrossRefGoogle Scholar
See supra note 1.Google Scholar
See Sheehy, et al., supra note 2.Google Scholar
Greer, J. W., “End-Stage Renal Disease and Medicare,” Health Care Financing Review 24 (2003): 15; Mendeloff, J., Ko, K., Roberts, M. S., Byrne, M., Dew, M. A., “Procuring Organ Donors as a Health Investment: How Much should we be Willing to Spend?” Transplantation 78 (2004): 1704–10.Google Scholar
USRDS (U.S. Renal data System), 2005, Annual Data Report at <http://www.usrds.org/adr.htm> (last visited February 6, 2006).+(last+visited+February+6,+2006).>Google Scholar
See Eggers, , supra note 3; Etzioni, , supra note 15; Mates, A. J. and Schnitzler, M., “Payment for Living Donors (Vendor) Kidneys: A Cost-Effective Analysis,” American Journal of Transplantation 4 (2003): 216221.Google Scholar
See Mendeloff, et al., supra note 19.Google Scholar
Institute of Medicine, Organ Procurement and Transplantation: Assessing Current Policies and the Potential Impact of the DHHS Final Rule (Washington, DC: National Academy Press, 1999): at 131.Google Scholar
Department of Health and Human Services, Organ Donor Registries: A Useful, but Limited, Tool, available at <http://www.organdonor.gov/oigdonorregistries.pdf> (last visited January 20, 2006).+(last+visited+January+20,+2006).>Google Scholar
See Sheehy, et al., supra note 2; Ploeg, R. J., Niesing, J., Sieber-Rasch, M. H. et al., “Shortage of Donation Despite an Adequate Number of Donors: A Professional Attitude?” Transplantation 76 (2003): 948955.Google Scholar
Johnson, E. J. and Goldstein, D., “Do Default Save Lives?” Science 302 (2003): 13381339; Sunstein, C. R., Thaler, R. H., “Libertarian Paternalism is not an Oxymoron,” University of Chicago Law Review 70 (2003): 1159–1202.CrossRefGoogle Scholar
Id.; Abadie, A., Gay, S., “The Impact of Presumed Consent Legislation on Cadaveric Organ Donation: A Cross Country Study,” National Bureau of Economic Research, Working Paper No. 10604, July 2004, available at <http://www.nber.org/papers/W10604> (last visited January 20, 2006).+(last+visited+January+20,+2006).>Google Scholar
See supra note 8; Johnson, , supra note 27; Sunstein, , supra note 27.Google Scholar
See Sheehy, , supra note 2; supra note 8; Sade, R. M., Kay, N., Pitzer, S., Drake, P., Baligna, P., Haines, S., “Increasing Organ Donation: A Successful New Concept,” Transplantation 74 (2002): 1142–46.; Siminoff, L. A., Gordon, N., Hewlett, J., Arnold, R. M., “Factors Influencing Families' Consent for Donation of Solid Organs for Transplantation,” JAMA 286 (2001): 71–7; Ashkenazi, T., Berman, M., Ami, Ben S., Fadila, A., Aravot, D., “A Bridge Between Hearts: Mutual Organ Donation by Arabs and Jews in Israel,” Transplantation 77 (2004): 151–5.Google Scholar
Siegal, G. and Bonnie, R. J., “Reflections on Fairness in UNOS Allocation Policies,” American Journal of Bioethics 5, no. 4 (2005): 2829.CrossRefGoogle Scholar
See supra note 8; Etzioni, , supra note 15; Veatch, R. M., “The Myth of Presumed Consent: Ethical Problems in Organ Procurement Strategies,” Transplantation Proceedings 27 (1995): 1888–92.Google Scholar
Siminoff, L. A., Lawrence, R. H., Arnold, R. M., “Comparison of Black and White Families' Experiences and Perceptions Regarding Organ Donation Requests,” Critical Care Medicine 31 (2003): 146–51.CrossRefGoogle Scholar
See Sheehy, , supra note 2; Abadie, , supra note 28; Wendler, D., Dickert, N., “The Consent Process for Cadaveric Organ Procurement: How does it Work? Can it be Improved?” JAMA 285 (2001): 329333.Google Scholar
See Wendler, , supra note 36.Google Scholar
40. UAGA, 8A U.L.A. § 2(h) (1987).Google Scholar
See Wendler, , supra note 36; Capron, A. M., “Reexamining Organ Transplantation,” JAMA 285 (2001): 334336.Google Scholar
See supra note 5.Google Scholar
Hodge, J. G., Gostin, L. O., “School Vaccination Requirements: Historical, Social and Legal Perspectives,” Kentucky Law Journal 90 (2001–2002): 831890.Google Scholar
See Siminoff, , supra note 34; Capron, , supra note 39.Google Scholar
See Mendeloff, , supra note 19.Google Scholar